Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma

Background Previously, we proposed expanded selection criteria for liver transplantation (LT) for hepatocellular carcinoma (HCC), the Kyoto criteria, involving a combination of tumor number ≤10, maximal diameter of each tumor ≤5 cm, and serum des-gamma-carboxy prothrombin levels ≤400 mAU/mL, and we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgery 2013-11, Vol.154 (5), p.1053-1060
Hauptverfasser: Kaido, Toshimi, MD, PhD, Ogawa, Kohei, MD, PhD, Mori, Akira, MD, PhD, Fujimoto, Yasuhiro, MD, PhD, Ito, Takashi, MD, PhD, Tomiyama, Koji, MD, PhD, Takada, Yasutsugu, MD, PhD, Uemoto, Shinji, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Previously, we proposed expanded selection criteria for liver transplantation (LT) for hepatocellular carcinoma (HCC), the Kyoto criteria, involving a combination of tumor number ≤10, maximal diameter of each tumor ≤5 cm, and serum des-gamma-carboxy prothrombin levels ≤400 mAU/mL, and we have used these criteria since January 2007. In the present study, the usefulness of the criteria was validated prospectively as well as retrospectively. Methods One hundred ninety-eight patients with HCC who underwent living donor LT (LDLT) from February 1999 through December 2011 were enrolled in this study. Overall survival and recurrence rates were investigated in patients classified according to the Kyoto criteria, the Milan criteria, or previous treatments for HCC. Tumor biological aggressiveness, including microvascular invasion and histologic differentiation, according to selection criteria was also examined. Results The 5-year overall survival for patients within the Kyoto criteria ( n = 147; 82%) was greater than that for the 49 patients exceeding them ( n = 49; 42%; P < .001). The 5-year recurrence rate for patients within the Kyoto criteria (4.4%) was less than that for patients exceeding them (51%; P  
ISSN:0039-6060
1532-7361
DOI:10.1016/j.surg.2013.04.056